Prenosis, which is based in Chicago, has announced that it will work with Roche Diagnostics to bring its Sepsis ImmunoScore tool to hospitals across the country.
In a landmark development poised to reshape the landscape of medical diagnostics, the U.S. Food and Drug Administration (FDA) has officially sanctioned Prenosis' pioneering artificial intelligence (AI) tool designed for the early detection of sepsis.
/PRNewswire/ Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA issued an.